Search results for ERK1

Mitogen-Activated Protein Kinase 1 and 3 / ERK1/2 (MAPK1/MAPK3) Antibody, Abbexa, abx232844

ERK1/2 Antibody is a Rabbit Polyclonal against ERK1/2.

Mitogen-Activated Protein Kinase 1 and 3 / ERK1/2 (MAPK1/MAPK3) Antibody, Abbexa, abx012726

Rabbit polyclonal antibody against MAPK1/3 protein. Immunogen region is Internal. Specificity is as follows for the reactive species: H:Y205/222, M:Y203/223, R:Y203/223.

Mitogen-Activated Protein Kinase 1 and 3 / ERK1/2 (MAPK1/MAPK3) Antibody, Abbexa, abx012998

Rabbit polyclonal antibody against MAPK1/3 protein. Immunogen region is Internal.

Anti-ERK1 (phospho T202 + T204) + ERK2 (phospho T185 + T187) antibody [4F6], Abcam, AB314199

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-ERK1 (phospho T202 + Y204) + ERK2 (phospho T185 + Y187) antibody [SP327], Abcam, AB223500

Mitogen-Activated Protein Kinase 1 and 3 / ERK1/2 (MAPK1/MAPK3) Antibody, Abbexa, abx011157

Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines and is an important target in the diagnosis and treatment of cancer. Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family as well as Mos and Tpl2/Cot. MEK1 and MEK2 are the primary MAPKKs in this pathway. MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK and the transcription factor Elk-1. p44/42 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs, along with MEK inhibitors such as U0126 and PD98059.

Mitogen-Activated Protein Kinase 1 and 3 / ERK1/2 (MAPK1/MAPK3) Antibody, Abbexa, abx327067

MAPK1/MAPK3 Antibody is a Rabbit Polyclonal against MAPK1/MAPK3.

Mitogen-Activated Protein Kinase 1 and 3 / ERK1/2 (MAPK1/MAPK3) Antibody, Abbexa, abx013071

Rabbit polyclonal antibody against p44/42 MAPK protein. Immunogen region is C-terminal.

Mitogen-Activated Protein Kinase 1 and 3 / ERK1/2 (MAPK1/MAPK3) Antibody, Abbexa, abx232847

ERK1/2 Antibody is a Mouse Monoclonal against ERK1/2.

Mitogen-Activated Protein Kinase 1 and 3 / ERK1/2 (MAPK1/MAPK3) Antibody (APC), Abbexa, abx447547

Erk1/2 Antibody (APC) is a Rabbit Polyclonal against ERK1.